Abound Wealth Management Has $715,000 Stock Holdings in Aflac Incorporated (NYSE:AFL)

Abound Wealth Management decreased its stake in shares of Aflac Incorporated (NYSE:AFLFree Report) by 4.6% during the 4th quarter, Holdings Channel reports. The institutional investor owned 6,908 shares of the financial services provider’s stock after selling 332 shares during the period. Abound Wealth Management’s holdings in Aflac were worth $715,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. International Assets Investment Management LLC raised its holdings in Aflac by 10,878.5% during the 3rd quarter. International Assets Investment Management LLC now owns 559,903 shares of the financial services provider’s stock worth $62,597,000 after purchasing an additional 554,803 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in Aflac by 471.4% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 600,000 shares of the financial services provider’s stock worth $67,080,000 after buying an additional 495,000 shares during the last quarter. Truist Financial Corp grew its position in shares of Aflac by 26.6% during the 2nd quarter. Truist Financial Corp now owns 1,929,662 shares of the financial services provider’s stock worth $172,338,000 after buying an additional 405,847 shares during the period. World Investment Advisors LLC bought a new stake in shares of Aflac in the 3rd quarter valued at about $42,290,000. Finally, Franklin Resources Inc. raised its position in shares of Aflac by 75.2% in the 3rd quarter. Franklin Resources Inc. now owns 776,131 shares of the financial services provider’s stock valued at $88,533,000 after acquiring an additional 333,083 shares during the period. Institutional investors own 67.44% of the company’s stock.

Insider Activity

In related news, EVP Audrey B. Tillman sold 24,744 shares of the stock in a transaction on Friday, December 27th. The stock was sold at an average price of $103.40, for a total value of $2,558,529.60. Following the sale, the executive vice president now owns 222,618 shares in the company, valued at approximately $23,018,701.20. This represents a 10.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.90% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on AFL shares. Wells Fargo & Company upped their target price on shares of Aflac to $107.00 and gave the company a “hold” rating in a research note on Tuesday, December 3rd. StockNews.com upgraded Aflac from a “sell” rating to a “hold” rating in a report on Wednesday, January 8th. Keefe, Bruyette & Woods lowered their price target on Aflac from $108.00 to $107.00 and set a “market perform” rating for the company in a report on Friday. Barclays lifted their price objective on Aflac from $96.00 to $98.00 and gave the company an “underweight” rating in a report on Monday, January 6th. Finally, Evercore ISI dropped their target price on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a report on Wednesday, December 4th. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $102.29.

View Our Latest Report on Aflac

Aflac Stock Up 1.4 %

NYSE:AFL traded up $1.40 on Monday, hitting $102.39. 909,120 shares of the company’s stock were exchanged, compared to its average volume of 1,572,844. The company has a market cap of $56.88 billion, a P/E ratio of 15.42, a price-to-earnings-growth ratio of 2.09 and a beta of 1.00. The firm has a 50-day moving average price of $106.63 and a 200-day moving average price of $104.93. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.08 and a quick ratio of 0.08. Aflac Incorporated has a 52 week low of $75.07 and a 52 week high of $115.50.

Aflac (NYSE:AFLGet Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share for the quarter, topping the consensus estimate of $1.69 by $0.47. The firm had revenue of $2.95 billion for the quarter, compared to analyst estimates of $4.30 billion. Aflac had a return on equity of 16.34% and a net margin of 22.02%. The business’s quarterly revenue was down 40.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.84 EPS. As a group, analysts expect that Aflac Incorporated will post 7.27 EPS for the current fiscal year.

Aflac Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Stockholders of record on Wednesday, February 19th will be given a $0.58 dividend. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.27%. The ex-dividend date is Wednesday, February 19th. This is an increase from Aflac’s previous quarterly dividend of $0.50. Aflac’s dividend payout ratio (DPR) is 34.94%.

Aflac Company Profile

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Recommended Stories

Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFLFree Report).

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.